What is Innospec's impairment charges?

Innospec (IOSP) reported impairment charges of $22.9M in Q3 2025.

What does impairment charges mean?

Non-cash asset impairment charges added back in the operating cash flow reconciliation since they don't represent cash outflows.

Innospec IOSP Impairment Charges

Impairment Charges at other companies

AshlandASH

-$706M-6,518%

Eastman ChemicalEMN

$33M—

ChemoursCC

$1M0.0%

IngevityNGVT

$2.8M—

AvientAVNT

$0-100%

Segments

By segment

See full

Fuel Specialties$0—

Oilfield Services$0—

Performance Chemicals$0—

Other financials

Income statement

See full

Revenue$453.2M+2.8%

Gross profit$123.5M-1.3%

Operating income$36.5M-14.1%

Net income$30.4M-7.3%

EPS (diluted)$1.22-6.9%

Balance sheet

See full

Cash & equivalents$289.1M-3.6%

Total debt$50.6M+14.0%

Total equity$1.3B+6.7%

Total assets$1.8B+2.5%

Cash flow

See full

Operating cash flow$17.6M-37.8%

CapEx$8.9M+6.0%

Free cash flow$8.7M-56.3%

Valuation

See full

Market cap$2.05B-23.6%

Profitability

See full

Gross margin27.4%-1.3pp

Operating margin6.9%-2.6pp

Net margin6.4%—

FCF margin4.5%-1.1pp

Returns & leverage

See full

Return on equity8.8%—

Debt / equity0×0.0×

Current ratio3×+0.3×

Where this comes from

Reported directly by Innospec in its filing.

Tagged under the XBRL concept us-gaap:ImpairmentOfLongLivedAssetsHeldForUse.

The official record: Innospec’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Innospec's impairment charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Innospec's impairment charges?: Innospec (IOSP) reported impairment charges of $22.9M in Q3 2025.
What does impairment charges mean?: Non-cash asset impairment charges added back in the operating cash flow reconciliation since they don't represent cash outflows.